1,4-dihydropyridine has been researched along with Disease Exacerbation in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamura, A | 1 |
| Engi, H | 1 |
| Anderson, G; Austin, PC; Bell, CM; Brotchie, J; Fox, S; Gruneir, A; Marras, C; Rochon, P; Wang, X | 1 |
| Bakris, GL; Greene, T; Hebert, L; Lea, J; Lipkowitz, M; Massry, S; Middleton, J; Miller, E; Rostand, SG; Smith, W | 1 |
| Ferentinou, E; Kaperonis, N; Karakasis, F; Kourvelou, C; Ntatsis, G; Papagalanis, N; Ziakka, S | 1 |
1 review(s) available for 1,4-dihydropyridine and Disease Exacerbation
| Article | Year |
|---|---|
Molecular Mechanism of Dihydropyridine Ca
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Dihydropyridines; Disease Models, Animal; Disease Progression; Humans; Hypertension, Pulmonary; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Nicardipine; Pulmonary Artery; Rats; Receptors, Calcium-Sensing; Up-Regulation; Vascular Remodeling; Vasoconstriction | 2016 |
1 trial(s) available for 1,4-dihydropyridine and Disease Exacerbation
| Article | Year |
|---|---|
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Prognosis; Proteinuria; Ramipril; Risk Factors; Treatment Outcome; United States | 2005 |
3 other study(ies) available for 1,4-dihydropyridine and Disease Exacerbation
| Article | Year |
|---|---|
[Perspectives of inhibition of multidrug resistance during cancer chemotherapy, in vitro and in vivo experiments].
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cytomegalovirus; Dihydropyridines; Disease Progression; Diterpenes; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; HSP90 Heat-Shock Proteins; Humans; Mice; Mice, Inbred DBA; Phenothiazines; Phenotype; Propylamines; Tylosin; Verapamil | 2009 |
Dihydropyridine calcium channel blockers and the progression of parkinsonism.
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Disease Progression; Female; Humans; Hypertension; Male; Parkinsonian Disorders; Retrospective Studies | 2012 |
Calcium channels blockers and progression of kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria | 2007 |